CD19 CAR T Therapy Is Feasible in Patients with Pemphigus Vulgaris Treated Without Lymphodepletion in the RESET-PV TrialCD19 CAR T疗法在未接受淋巴清除治疗的寻常型天疱疮患者中是可行的(RESET-PV试验)BloodIF23.12026-05-280OAAI
Case study of CD19 CAR T therapy in a subject with immune-mediate necrotizing myopathy treated in the RESET-Myositis phase I/II trialMOLECULAR THERAPYIF122024-11-011OAAI
The Chemokine Receptor CXCR3 Promotes CD8+ T Cell Accumulation in Uninfected Salivary Glands but Is Not Necessary after Murine Cytomegalovirus InfectionJOURNAL OF IMMUNOLOGYIF3.42018-02-0135OAAI